Loop Diuretics in Infants with Heart Failure

Area of Science:

• Pediatric Cardiology
• Congenital Heart Disease
• Heart Failure Management

Background:

• Surgical management of congenital heart disease (CHD) has advanced significantly over the past 50 years.
• Infants with clinically significant CHD are at high risk for developing heart failure (HF).
• While adult HF management is well-established and evidence-based, data for pediatric HF, particularly in infants, is limited.

Purpose of the Study:

• To highlight the critical need for expanded research and understanding of heart failure (HF) in infants with congenital heart disease (CHD).
• To underscore the importance of developing evidence-based guidelines for HF management in the pediatric population.
• To identify upcoming areas of interest concerning medical and interventional approaches for HF secondary to CHD in infants.

Main Methods:

• This is a review and perspective piece, not an original research study.
• It synthesizes current knowledge on CHD and HF in the pediatric population.
• It identifies gaps in the literature regarding infant HF management.

Main Results:

• Significant progress has been made in CHD surgical interventions.
• There is a substantial knowledge gap in the management of heart failure (HF) in infants with CHD.
• The indications and implications of various treatments for HF secondary to CHD in infants require further investigation.

Conclusions:

• There is an urgent need to expand the ability to prevent, detect, and manage heart failure (HF) in the pediatric population, especially in infants with congenital heart disease (CHD).
• Further research into pediatric HF management is essential to improve outcomes for affected infants.
• Developing specific guidelines for HF in infants with CHD is a critical future direction.